Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.54
-0.95 (-10.01%)
At close: May 18, 2026, 4:00 PM EDT
8.74
+0.20 (2.34%)
Pre-market: May 19, 2026, 8:43 AM EDT
Kyverna Therapeutics Employees
Kyverna Therapeutics had 130 employees as of December 31, 2025. The number of employees increased by 18 or 16.07% compared to the previous year.
Employees
130
Change (1Y)
18
Growth (1Y)
16.07%
Revenue / Employee
n/a
Profits / Employee
-$1,203,077
Market Cap
516.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 130 | 18 | 16.07% |
| Dec 31, 2024 | 112 | 16 | 16.67% |
| Dec 31, 2023 | 96 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Valneva SE | 674 |
| Rigel Pharmaceuticals | 174 |
| Cabaletta Bio | 156 |
| Prime Medicine | 146 |
| Prothena Corporation | 67 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
KYTX News
- 1 day ago - Kyverna Therapeutics CFO Marc Grasso to step down, Greg Martini to succeed - TheFly
- 1 day ago - Kyverna Therapeutics Names Greg Martini as Chief Financial Officer - GlobeNewsWire
- 4 days ago - Kyverna Therapeutics price target raised to $25 from $20 at H.C. Wainwright - TheFly
- 5 days ago - Kyverna Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 days ago - Kyverna Therapeutics price target lowered to $29 from $30 at JPMorgan - TheFly
- 6 days ago - Kyverna Therapeutics reports Q1 EPS (66c), consensus (73c) - TheFly
- 6 days ago - Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 6 days ago - Kyverna Therapeutics Earnings release: Q1 2026 - Filings